KD Deadline Alert: Contact Kirby McInerney by April 13!

Recent Developments and Class Action Alert

Kyndryl Holdings, Inc. (NYSE: KD), an IT infrastructure services provider spun off from IBM in late 2021, is facing a securities class-action lawsuit following a sharp stock price collapse (markets.chroniclejournal.com). Investors who incurred significant losses are encouraged to contact the law firm Kirby McInerney by April 13, 2026 to seek lead-plaintiff status in this case (markets.chroniclejournal.com). The lawsuit centers on allegations that Kyndryl’s financial statements during the relevant period were materially misstated, that the company had inadequate internal controls, and that it failed to timely file its quarterly financial report for the quarter ended Dec. 31, 2025 (markets.chroniclejournal.com). On February 9, 2026, Kyndryl’s CFO and General Counsel both resigned effective immediately amid an internal review of “cash management practices” and financial reporting controls prompted by voluntary SEC document requests (markets.chroniclejournal.com). This news sent Kyndryl’s stock plunging ~55% in one day – from about $23.60 to $10.59 per share (www.crn.com) – wiping out over $2 billion in market value and triggering multiple investor lawsuits. The analysis below examines Kyndryl’s financial profile, dividend policy, leverage, valuation, and the risks/red flags that led to this crisis, in order to inform shareholders ahead of the April 13 deadline.

Dividend Policy & Yield

No Dividend: Since its spin-off, Kyndryl has not paid any dividends to shareholders. The company confirmed that it “did not declare any stock dividends” in the periods since listing (www.sec.gov). As a result, Kyndryl’s dividend yield is 0%, and investors have not received cash returns via dividends (www.sec.gov). This dividend policy is not unusual for a recent spin-off focused on restructuring – management has prioritized using cash to stabilize operations and invest in growth and efficiency improvements rather than paying dividends. In fact, Kyndryl initiated a modest share repurchase program instead of dividends, buying back about $94 million of its stock in FY2025 (www.sec.gov). The lack of a dividend means income-oriented investors likely steer clear of KD, and the stock’s total return depends entirely on price appreciation (or depreciation). Given Kyndryl’s ongoing turnaround efforts and recent turmoil, any potential future dividend is likely on hold until the company achieves consistent profitability and stronger free cash flow generation.

Leverage and Debt Maturities

Debt Load: Kyndryl inherited a substantial debt load at spin-off but has manageable maturities and ample liquidity. As of March 31, 2025, the company carried $3.19 billion of total debt (including finance leases), or about $3.04 billion net of issuance discounts (www.sec.gov). This consisted of a small term loan and several series of unsecured notes issued in 2021 to fund the spin-off. Key components include a ~$700 million note due October 2026 (2.05% coupon), $500 million due 2028 (2.70%), $650 million due 2031 (3.15%), $500 million due 2034 (6.35% coupon, swapped to ~3.8% effective), and $550 million due 2041 (4.10%) (www.sec.gov). The debt maturity profile is relatively well-staggered: only $29 million of principal comes due by March 2026, followed by a $710 million bulge in the fiscal year ending March 2027 (mainly the October 2026 notes) (www.sec.gov). No other significant maturities occur until $500 million in FY2029 (the 2028 notes), with the rest ($1.7 billion) due from 2031 onward (www.sec.gov).

Refinancing Risk: In the near term, Kyndryl’s biggest hurdle is refinancing or repaying the $700 million 2026 note. That bond was issued at a low 2.05% rate (www.sec.gov), and any new debt will likely carry a much higher interest rate given today’s higher yields and the company’s recent financial control issues. However, Kyndryl has a large revolving credit facility in place to manage obligations: a $3.15 billion multi-currency revolving credit line (amended in 2023/2025) that was extended to mature in March 2030 (www.sec.gov) (www.sec.gov). As of March 2025, the company had only modest short-term borrowings ($39 million) under this facility (www.sec.gov), leaving substantial unused capacity. Management asserts that existing cash ($1.79 billion at 3/31/25) and the revolver are sufficient to meet anticipated needs for at least the next 12 months (www.sec.gov) (www.sec.gov). Indeed, Kyndryl’s cash balance of ~$1.8 billion provides a buffer to cover the 2026 maturities if necessary (www.sec.gov). Overall leverage appears moderate relative to the business size, but the credit rating and refinancing terms could worsen if the current accounting investigation raises lenders’ concerns. Investors should monitor how Kyndryl addresses the 2026 debt – e.g. using cash on hand, drawing the revolver, or issuing new debt – especially in light of the company’s internal control troubles.

Coverage and Liquidity

Interest Coverage: By reported metrics, Kyndryl’s debt service coverage looked very strong prior to the recent upheaval. In the fiscal year ended March 31, 2025, Kyndryl had Adjusted EBITDA of $2.52 billion (www.sec.gov) and an interest expense of only about $100 million (www.sec.gov). This implies an EBITDA/interest coverage ratio of roughly 25×, indicating ample ability to meet interest obligations. Even on a net income basis, FY2025 EBIT was healthy enough to cover the ~$100 million interest many times over. Similarly, net leverage was low – net debt (~$1.4 billion after cash) was only ~0.6× Adjusted EBITDA, well within the 3.5× debt/EBITDA covenant on the revolver (www.sec.gov). Kyndryl remained in full compliance with all debt covenants as of its last report (www.sec.gov). These figures suggest solid liquidity and financial flexibility under normal conditions.

However, the quality of Kyndryl’s earnings and cash flow has been called into question. Short-seller Gotham City Research alleged in March 2025 that Kyndryl “manipulates reported adjusted EBITDA and free cash flow to artificially give the appearance that it generates profits and cash flow; while in reality, KD generates losses and burns cash.” (www.tradingview.com) The report pointed to confusing accounting for related-party costs payable to IBM and claimed Kyndryl stopped disclosing certain IBM cost figures after 2023 (www.tradingview.com). If these allegations are true, Kyndryl’s actual interest coverage and free cash flow coverage of debt could be much weaker than the headline numbers. It’s notable that Kyndryl’s own management has emphasized improving cash generation as a priority – e.g. targeting stronger working capital management – yet an SEC inquiry into “cash management practices” (markets.chroniclejournal.com) now casts doubt on how effectively cash was handled. The company has stated in early 2026 that it does not expect the accounting review to impact previously reported financial statements (www.crn.com), but until the review is complete and filings are current, investors may view Kyndryl’s coverage ratios with caution. In summary, reported liquidity and coverage were robust, but there is a cloud over those figures pending clarity on the internal investigation and the true free cash flow generation of the business.

Valuation and Comparables

Recent Performance: Kyndryl only recently achieved bottom-line profitability, making traditional valuation metrics volatile. After posting large net losses in its first year post-spinoff (a $1.37 billion loss in FY2023), the company’s net result improved to a $340 million loss in FY2024 and then a $252 million net profit in FY2025 (www.sec.gov). This swing to profit was aided by cost-cutting and one-off gains – for example, FY2025 net income included a $138 million after-tax gain from an asset sale, alongside improved margins from pruning low-margin contracts (www.sec.gov). On an earnings-per-share basis, FY2025 was $1.09 in EPS (versus losses of $1.48 and $6.06 per share in the prior two years) (www.sec.gov). Kyndryl’s stock price had responded positively to these improvements through late 2025, rising into the mid-$20s per share. However, the events of February 2026 dramatically reset the valuation. At the pre-crisis price of ~$23.60, Kyndryl was valued around 21.5× trailing earnings (using $1.09 EPS). After the collapse to about $10.59 (www.crn.com), the stock trades at roughly 9–10× trailing earnings, reflecting a steep drop in investor confidence. It’s worth noting that even the “pre-crisis” P/E near 22× was not especially high for the broader market – but in Kyndryl’s case, investors likely doubted the sustainability of that $1+ EPS given revenue shrinkage (see below) and now potential restatement risk.

EV/EBITDA and Peer Comparison: Using a cash-flow metric, Kyndryl superficially appears very cheap. Based on FY2025 Adjusted EBITDA of ~$2.5 billion and the current enterprise value (market cap ~$2.2 billion at $10/share plus $3.0 billion debt minus $1.8 billion cash), Kyndryl’s EV/EBITDA is on the order of 2×. This is an extremely low multiple, even for a low-growth, services-oriented business. Notably, peers like DXC Technology (another IT services firm undergoing turnaround) trade at similarly depressed multiples – DXC’s EV/EBITDA was about 2.1× in late 2025 (www.valueinvesting.io). Such a low valuation suggests the market is pricing in further earnings erosion, high execution risk, or possible financial trouble ahead. For additional context, Kyndryl’s price-to-sales ratio is only ~0.2× (with $15 billion revenue in FY2025 (www.sec.gov) vs ~$3 billion market cap post-drop), which is a fraction of most tech-related companies. Of course, Kyndryl’s business is much lower margin than a typical software firm, and its revenues have been declining (mid-single-digit percentage declines annually as it sheds unprofitable contracts) (www.sec.gov). Investors appear unwilling to assign a higher multiple until Kyndryl can prove it can stabilize revenues and generate consistent free cash flow. In summary, valuation metrics like EV/EBITDA and P/S indicate a distressed or deep-value stock. If the company’s turnaround succeeds and accounting fears subside, there could be significant upside from these levels. Conversely, if earnings quality issues are real or the business continues to contract, even a 2× EV/EBITDA could be a value trap.

Risks and Red Flags

Internal Control Breakdown: The clearest red flag is the recent revelation of potential internal control failures. The abrupt resignation of CFO David Wyshner and General Counsel Edward Sebold in February 2026 (with an interim CFO and GC immediately appointed) strongly signals that something was amiss in Kyndryl’s financial oversight (www.sec.gov). Kyndryl disclosed that it is reviewing its cash management practices, financial disclosures, and the effectiveness of internal controls after receiving inquiries from the SEC’s Enforcement Division (www.crn.com). The fact that the company could not file its Q3 FY2026 10-Q on time, and had to announce that publicly, indicates a serious internal issue – possibly a material weakness or accounting error related to cash or revenue recognition (markets.chroniclejournal.com). These events raise the risk of a financial restatement or at least a loss of management credibility. Even if Kyndryl believes its financials won’t ultimately change, the market reaction shows a huge trust deficit now. Until the internal review and SEC inquiry are resolved, this cloud will hang over the stock. There’s also the specter of regulatory penalties or costly remediation efforts if deficiencies in controls are confirmed.

Short-Seller Allegations: Prior to the internal control crisis, Kyndryl was already under the scrutiny of at least one aggressive short-seller. In March 2025, Gotham City Research published a report accusing Kyndryl of accounting manipulation – specifically, inflating adjusted EBITDA and free cash flow and hiding rising costs (www.tradingview.com). Gotham contended that Kyndryl had “presented a misleading picture of profitability and cash generation” and was actually burning cash (ng.investing.com). The report highlighted suspicious inconsistencies in how Kyndryl reported its expenses payable to IBM, its former parent and largest supplier (www.tradingview.com). Gotham also warned that Kyndryl faces “much higher…costs to IBM than the market thinks”, estimating an extra $1–2 billion in service costs could hit in coming years as legacy pricing arrangements expire (www.techpartner.news). This would squeeze margins and “unravel the misleading narratives” management has used to promote the stock (www.techpartner.news). Gotham City Research went so far as to predict Kyndryl’s stock could plunge to between $4.70 and $11.50 per share – or even $0 in the worst case (cincodias.elpais.com). Kyndryl’s response was to vehemently deny these claims as “inaccurate and deliberately misleading” (cincodias.elpais.com) (www.techpartner.news). Nevertheless, the report caused a one-day 14–16% drop in Kyndryl’s stock when it came out (www.tradingview.com) (cincodias.elpais.com), reflecting that some investors found the allegations credible. In hindsight, the emergence of actual internal control issues within the year gives weight to concerns that Kyndryl’s financial reporting might not have been airtight. The short-seller allegations represent a risk that further accounting or business model problems could surface. Even absent outright fraud, Kyndryl’s strategy of eliminating low-margin sales and relying on partnership-driven revenue has yet to prove it can return the company to growth. The ongoing decline in sales (–6% YoY in FY2025) (www.sec.gov) is a risk factor, as it indicates potential difficulty replacing lost contracts with new business.

Financial Performance Risks: Beyond the accounting controversy, Kyndryl faces typical business risks for an IT services company in transformation. Its revenues have been shrinking (from $17.0 billion in FY2023 to $15.1 billion in FY2025) (www.sec.gov) as the firm sheds unprofitable contracts and faces competitive pressures. While this strategy improved margins in the short term, continued revenue attrition could eventually outpace cost cuts. The IT infrastructure management market is highly competitive (with players like Accenture, IBM Global Services, DXC, etc.), and Kyndryl must rapidly pivot to higher-margin offerings such as cloud services, security, and consulting (“Kyndryl Consult”) to stabilize its top line. There is execution risk in this pivot – Kyndryl’s workforce and salesforce need to adapt from legacy outsourcing contracts to more modern, integrated services. Additionally, client concentration or loss of major customers could pose a risk; IBM was a significant customer/partner post-spin, and any strain in that relationship (especially amid the cost disputes) could hurt Kyndryl’s pipeline. Macroeconomic factors also play a role: many enterprises are optimizing IT spend, and legacy infrastructure projects might be curtailed. Kyndryl’s relatively thin margins leave less room for error if costs rise (e.g. labor inflation or the predicted increase in IBM license fees). Finally, the class-action lawsuits themselves are a risk – while such shareholder suits often take time and may settle, they will consume management attention and legal expenses. The overhang of litigation and the SEC probe means headline risk remains elevated: any further negative disclosures or surprises could send the stock lower, whereas successful resolution could lead to a relief rally. In short, Kyndryl is navigating a minefield of operational and financial risks, and investors should be cognizant of these red flags before drawing conclusions about the company’s intrinsic value.

Open Questions for Investors

Given the unsettled situation at Kyndryl, several open questions remain that could determine the stock’s trajectory in the coming months:

– Will Kyndryl’s financial statements require restatement? The company claims to expect no changes to its balance sheet or P&L from the accounting review (www.crn.com) – but investors won’t know for sure until the internal investigation (and SEC inquiry) conclude. If material misstatements are confirmed (as alleged in the lawsuit), the reputational damage and potential revisions to earnings could be severe.

– How quickly can the internal control issues be fixed? Kyndryl has installed an interim CFO and taken other remedial steps (www.crn.com), but regaining trust will require a clean bill of health on its next filings. Will new permanent financial leadership be brought in, and can the Audit Committee’s review put proper safeguards in place to prevent future lapses?

– What are the implications of the SEC Enforcement Division’s involvement? A “voluntary document request” from the SEC (www.crn.com) can sometimes lead to a formal investigation. It remains to be seen if the SEC finds any violations that merit penalties or mandates for Kyndryl. Even if no enforcement action follows, the mere presence of SEC scrutiny raises the bar for Kyndryl’s financial transparency going forward.

– Can Kyndryl execute its turnaround and return to growth? The core challenge is that revenue is still contracting (www.sec.gov). Kyndryl’s strategy of focusing on higher-margin business (cloud partnerships, digital transformation projects, etc.) must begin to offset the run-off in legacy deals. Investors will be watching upcoming quarterly results for signs of stabilizing sales or new deal wins. A return to organic growth (even low single digits) would greatly improve sentiment, whereas continued declines could validate bearish views.

– How will the looming debt refinancing be handled? With ~$700 million coming due in late 2026 (www.sec.gov), does Kyndryl plan to refinance in 2025 (potentially at high interest rates) or use cash/revolver capacity to pay it off? The outcome will affect interest costs and liquidity. A successful refinancing or debt paydown would signal confidence, while difficulties rolling over the debt might raise going-concern questions.

– What is the endgame for shareholders caught in this downturn? At around $10 per share, Kyndryl trades at a fraction of its spin-off value. Is the stock undervalued – a turnaround bargain if operations normalize – or do the recent events portend further decline? Notably, Gotham City’s worst-case scenario of a near-zero stock price (cincodias.elpais.com), while extreme, reflects the bear case that Kyndryl could destroy equity value if it cannot fix its issues. Conversely, any positive developments (resolution of the SEC matter, a stabilizing Q4 FY2026 report, etc.) could cause a sharp rebound from these distressed levels. Shareholders should consider whether to hold through the volatility or pursue legal remedies to recoup losses – hence the importance of the April 13 deadline to contact Kirby McInerney for those seeking to join the class action.

In summary, Kyndryl faces a critical juncture: it must restore financial credibility and operational momentum to escape the shadow of recent events. The coming quarters – and the findings of ongoing investigations – will be pivotal in determining if KD can regain investor confidence or if it will continue to confront legal and financial challenges. Investors are urged to stay informed through reliable sources (SEC filings, company updates, and reputable financial news) as this situation unfolds, and to take action by the April 13 deadline if they wish to participate in the shareholder litigation.

For informational purposes only; not investment advice.